• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

球囊血管成形术——安德烈亚斯·格里茨克医学博士的遗产(1939-1985)。

Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985).

机构信息

University of Zürich , Zürich , Switzerland.

Heinrich Heine-Universität , Düsseldorf , Germany.

出版信息

Front Cardiovasc Med. 2014 Dec 29;1:15. doi: 10.3389/fcvm.2014.00015. eCollection 2014.

DOI:10.3389/fcvm.2014.00015
PMID:26664865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4671350/
Abstract

In 1974, at the Medical Policlinic of the University of Zürich, German-born physician-scientist Andreas Grüntzig (1939-1985) for the first time applied a balloon-tipped catheter to re-open a severely stenosed femoral artery, a procedure, which he initially called "percutaneous transluminal dilatation". Balloon angioplasty as a therapy of atherosclerotic vascular disease, for which Grüntzig and Charles T. Dotter (1920-1985) received a nomination for the Nobel Prize in Physiology or Medicine in 1978, became one of the most successful examples of translational medicine in the twentieth century. Known today as percutaneous transluminal angioplasty (PTA) in peripheral arteries or percutaneous transluminal coronary angioplasty (PTCA) or percutaneous coronary intervention (PCI) in coronary arteries, balloon angioplasty has become the method of choice to treat patients with acute myocardial infarction or occluded leg arteries. On the occasion of the 40(th) anniversary of balloon angioplasty, we summarize Grüntzig's life and career in Germany, Switzerland, and the United States and also review the developments in vascular medicine from the 1890s to the 1980s, including Dotter's first accidental angioplasty in 1963. The work of pioneers of catheterization, including Pedro L. Fariñas in Cuba, André F. Cournand in France, Werner Forssmann, Werner Porstmann and Eberhard Zeitler in Germany, António Egas Moniz and Reynaldo dos Santos in Portugal, Sven-Ivar Seldinger in Sweden, and Barney Brooks, Thomas J. Fogarty, Melvin P. Judkins, Richard K. Myler, Dickinson W. Richards, and F. Mason Sones in the United States, is discussed. We also present quotes by Grüntzig and excerpts from his unfinished autobiography, statements of Grüntzig's former colleagues and contemporary witnesses, and have included hitherto unpublished historic photographs and links to archive recordings and historic materials. This year, on June 25, 2014, Andreas Grüntzig would have celebrated his 75(th) birthday. This article is dedicated to his memory.

摘要

1974 年,在苏黎世大学医学门诊部,德裔医师科学家安德烈亚斯·格里茨格(Andreas Grüntzig,1939-1985 年)首次应用球囊导管对严重狭窄的股动脉进行再通,他最初将该程序称为“经皮腔内血管成形术”。球囊血管成形术作为治疗动脉粥样硬化性血管疾病的一种疗法,格里茨格和查尔斯·T·多特(Charles T. Dotter,1920-1985 年)因此于 1978 年获得诺贝尔生理学或医学奖提名。该疗法成为 20 世纪转化医学最成功的范例之一。如今,在周围动脉中称为经皮腔内血管成形术(PTA),在冠状动脉中称为经皮腔内冠状动脉血管成形术(PTCA)或经皮冠状动脉介入治疗(PCI),球囊血管成形术已成为治疗急性心肌梗死或闭塞性腿部动脉患者的首选方法。值此球囊血管成形术 40 周年之际,我们总结了格里茨格在德国、瑞士和美国的生平和职业生涯,还回顾了从 19 世纪 90 年代到 20 世纪 80 年代血管医学的发展,包括多特在 1963 年首次意外实施的血管成形术。我们还讨论了导管插入术先驱的工作,包括古巴的佩德罗·L·法里尼亚斯(Pedro L. Fariñas)、法国的安德烈·F·考恩南(André F. Cournand)、维尔纳·福斯曼(Werner Forssmann)、维尔纳·波斯特曼(Werner Porstmann)和埃伯哈德·齐特勒(Eberhard Zeitler)、葡萄牙的安东尼奥·埃加斯·莫尼斯(António Egas Moniz)和雷纳尔多·多斯桑托斯(Reynaldo dos Santos)、瑞典的斯文-伊瓦尔·塞尔丁格(Sven-Ivar Seldinger)、以及美国的巴尼·布鲁克斯(Barney Brooks)、托马斯·J·福格蒂(Thomas J. Fogarty)、梅尔文·P·朱迪斯(Melvin P. Judkins)、理查德·K·迈勒(Richard K. Myler)、迪金森·W·理查兹(Dickinson W. Richards)和 F·梅森·索恩斯(F. Mason Sones)。我们还提供了格里茨格的引述和他未完成自传的摘录、他的前同事和同时代证人的陈述,并收录了迄今未发表的历史照片以及与档案录音和历史资料的链接。今年,也就是 2014 年 6 月 25 日,安德烈亚斯·格里茨格将迎来他的 75 岁生日。本文以此纪念他。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/78e80c7b4e9b/fcvm-01-00015-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/242edca5232b/fcvm-01-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/8be7ae51cac8/fcvm-01-00015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/d2f0c6eca00d/fcvm-01-00015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/f605eacb84f6/fcvm-01-00015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/6b57ee5a14a7/fcvm-01-00015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/fd6c8f4097a9/fcvm-01-00015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/7bf20a445bb3/fcvm-01-00015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/eca8c94f946a/fcvm-01-00015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/0ce7a613afa8/fcvm-01-00015-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/aa28fdf169d5/fcvm-01-00015-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/79fa7faeec5f/fcvm-01-00015-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/aa0ae2f6686d/fcvm-01-00015-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/8f5f11b14ab8/fcvm-01-00015-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/081a346b5049/fcvm-01-00015-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/e0485e05e6bb/fcvm-01-00015-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/fd206f9a1d50/fcvm-01-00015-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/78e80c7b4e9b/fcvm-01-00015-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/242edca5232b/fcvm-01-00015-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/8be7ae51cac8/fcvm-01-00015-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/d2f0c6eca00d/fcvm-01-00015-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/f605eacb84f6/fcvm-01-00015-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/6b57ee5a14a7/fcvm-01-00015-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/fd6c8f4097a9/fcvm-01-00015-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/7bf20a445bb3/fcvm-01-00015-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/eca8c94f946a/fcvm-01-00015-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/0ce7a613afa8/fcvm-01-00015-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/aa28fdf169d5/fcvm-01-00015-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/79fa7faeec5f/fcvm-01-00015-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/aa0ae2f6686d/fcvm-01-00015-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/8f5f11b14ab8/fcvm-01-00015-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/081a346b5049/fcvm-01-00015-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/e0485e05e6bb/fcvm-01-00015-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/fd206f9a1d50/fcvm-01-00015-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c0c/4671350/78e80c7b4e9b/fcvm-01-00015-g017.jpg

相似文献

1
Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985).球囊血管成形术——安德烈亚斯·格里茨克医学博士的遗产(1939-1985)。
Front Cardiovasc Med. 2014 Dec 29;1:15. doi: 10.3389/fcvm.2014.00015. eCollection 2014.
2
[Thirty years of the balloon catheter--A. Grüntzig and percutaneous balloon angioplasty].球囊导管的三十年——A. 格鲁恩齐格与经皮腔内血管成形术
Cas Lek Cesk. 2004;143(12):866-71.
3
Andreas Grüntzig's balloon catheter for angioplasty of peripheral arteries (PTA) is 25 years old.
Vasa. 1999 Feb;28(1):58-64. doi: 10.1024/0301-1526.28.1.58.
4
Voyaging in the vein: medical experimentation with heart catheters in the twentieth century.血管中的航行:20世纪心脏导管的医学实验
Nuncius. 2011;26(1):132-58. doi: 10.1163/182539111x569793.
5
[Pioneers of invasive cardiovascular medicine--Charles Theodore Dotter and colleagues: short historical review].
Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):131-7. doi: 10.2298/sarh1402131k.
6
Percutaneous transluminal coronary angioplasty.
Tokai J Exp Clin Med. 1986 May;11(2):71-86.
7
[Results of percutaneous transluminal angioplasty].
Herz. 1989 Feb;14(1):22-8.
8
The beginning of balloon conception and application in peripheral arterial disease.
J Invasive Cardiol. 2008 Mar;20(3):E85-7.
9
Percutaneous Transluminal Coronary Angioplasty经皮腔内冠状动脉成形术
10
F. Mason Sones Jr.: The Serendipitous Discovery of Coronary Angiography and Its Lasting Impact on Cardiology.小F. 梅森·索恩斯:冠状动脉造影术的意外发现及其对心脏病学的持久影响。
Cureus. 2024 May 25;16(5):e61080. doi: 10.7759/cureus.61080. eCollection 2024 May.

引用本文的文献

1
The Rise of Optical Coherent Tomography in Intracoronary Imaging: An Overview of Current Technology, Limitations, and Future Perspectives.光学相干断层扫描在冠状动脉内成像中的兴起:当前技术、局限性及未来展望综述
Rev Cardiovasc Med. 2025 Aug 29;26(8):38123. doi: 10.31083/RCM38123. eCollection 2025 Aug.
2
Drug-Coated Balloons for Coronary Interventions: A Focused Review.用于冠状动脉介入治疗的药物涂层球囊:聚焦综述
Methodist Debakey Cardiovasc J. 2025 Aug 12;21(4):37-53. doi: 10.14797/mdcvj.1607. eCollection 2025.
3
Drug-Coated Balloon PCI in Different Plaque Morphologies: A Narrative Review.

本文引用的文献

1
Advancing and Translating Knowledge in Vascular Medicine.推进和转化血管医学知识。
Front Cardiovasc Med. 2014 Oct 29;1:6. doi: 10.3389/fcvm.2014.00006. eCollection 2014.
2
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.药物涂层球囊与标准经皮腔内血管成形术治疗股浅动脉和腘动脉外周动脉疾病:IN.PACT SFA随机试验的12个月结果
Circulation. 2015 Feb 3;131(5):495-502. doi: 10.1161/CIRCULATIONAHA.114.011004. Epub 2014 Dec 3.
3
Endothelin-a receptor antagonism after renal angioplasty enhances renal recovery in renovascular disease.
不同斑块形态下的药物涂层球囊经皮冠状动脉介入治疗:一项叙述性综述
Biomedicines. 2025 Jun 14;13(6):1472. doi: 10.3390/biomedicines13061472.
4
PDA Stenting for Ductal-Dependent Cyanotic Congenital Heart Disease: History and View from 10,000 Feet.动脉导管未闭支架置入术治疗依赖动脉导管的青紫型先天性心脏病:历史与宏观视角
Pediatr Cardiol. 2024 Dec 17. doi: 10.1007/s00246-024-03737-w.
5
Stent, balloon and hybrid in PCI: could the whole be greater than the sum of its parts?经皮冠状动脉介入治疗中的支架、球囊及混合技术:整体能否大于部分之和?
Br J Cardiol. 2023 Nov 10;30(4):37. doi: 10.5837/bjc.2023.037. eCollection 2023.
6
Zero Radiation in the Cardiac Catheterization Laboratory: An Aspirational Goal or Moral Imperative?心导管实验室的零辐射:一个理想目标还是道德要求?
J Soc Cardiovasc Angiogr Interv. 2023 Oct 19;3(1):101131. doi: 10.1016/j.jscai.2023.101131. eCollection 2024 Jan.
7
Efficacy and Safety of a Polytetrafluoroethylene Membrane Wrapped a Single Layer of Sirolimus-Eluting Stent in a Porcine Coronary Perforation Model.聚四氟乙烯膜包裹单层西罗莫司洗脱支架在猪冠状动脉穿孔模型中的有效性和安全性
Rev Cardiovasc Med. 2022 Jun 24;23(7):233. doi: 10.31083/j.rcm2307233. eCollection 2022 Jul.
8
Femoro-popliteal endovascular interventions.股腘动脉腔内介入治疗
Wideochir Inne Tech Maloinwazyjne. 2024 Jun;19(2):187-197. doi: 10.5114/wiitm.2024.139548. Epub 2024 May 10.
9
Revascularization Modalities in Acute Coronary Syndrome: A Review of the Current State of Evidence.急性冠状动脉综合征的血运重建方式:证据现状综述
Cureus. 2023 Oct 17;15(10):e47207. doi: 10.7759/cureus.47207. eCollection 2023 Oct.
10
Is Intravascular Lithotripsy (IVL) Alone a Therapy for the Treatment of Aortoiliac Occlusive Disease (AIOD)?单纯血管内碎石术(IVL)能否作为治疗主髂动脉闭塞性疾病(AIOD)的一种疗法?
Cureus. 2023 Oct 23;15(10):e47537. doi: 10.7759/cureus.47537. eCollection 2023 Oct.
肾血管成形术后内皮素 A 受体拮抗作用可促进肾血管疾病中的肾脏恢复。
J Am Soc Nephrol. 2015 May;26(5):1071-80. doi: 10.1681/ASN.2014040323. Epub 2014 Nov 6.
4
2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.2013 年罗素·罗斯血管生物学纪念讲座:糖尿病加速动脉粥样硬化的细胞和分子机制。
Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):705-14. doi: 10.1161/ATVBAHA.113.301928.
5
The treatment of acute myocardial infarction: the Past, the Present, and the Future.急性心肌梗死的治疗:过去、现在和未来。
Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):9-12. doi: 10.1177/2048872612438026.
6
Prevention and endothelial therapy of coronary artery disease.冠状动脉疾病的预防和内皮治疗。
Curr Opin Pharmacol. 2013 Apr;13(2):226-41. doi: 10.1016/j.coph.2013.05.005. Epub 2013 Jun 4.
7
Mechanisms and therapy of atherosclerosis and its clinical complications.动脉粥样硬化及其临床并发症的机制与治疗。
Curr Opin Pharmacol. 2013 Apr;13(2):149-53. doi: 10.1016/j.coph.2013.05.001. Epub 2013 May 28.
8
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.心血管疾病患者临床管理中的二级预防。转诊与实施的核心要素、标准及结局指标:欧洲心血管预防与康复协会心脏康复分会的政策声明。经欧洲心脏病学会实践指南委员会认可。
Eur J Prev Cardiol. 2014 Jun;21(6):664-81. doi: 10.1177/2047487312449597. Epub 2012 Jun 20.
9
The rise of cardiovascular medicine.心血管医学的兴起。
Eur Heart J. 2012 Apr;33(7):838-45, 845a. doi: 10.1093/eurheartj/ehr452. Epub 2012 Mar 12.
10
Elias S. Hanna, MD, FACS, opens his heart to patients the world over.
Bull Am Coll Surg. 2011 Jun;96(6):22-3.